ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas	Neoplasms by Site, central nervous system cancer, neoplasm, nervous system disorder	Recruiting	Phase 1	2026-07-24		NCT03922555

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Astex Pharmaceuticals, Inc.	12
Massachusetts General Hospital	758

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Brigham and Women's Hospital	Boston	United States	511
Dana Farber Cancer Institute	Boston	United States	133
Massachusetts General Hospital Cancer Center	Boston	United States	178

Clinical trials